{
    "2021-01-29": [
        [
            {
                "time": "",
                "original_text": "华大基因：玉高林和高林同创累计减持占公司总股本1.46%的股份 减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "减持",
                        "总股本"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因召开业绩预告机构交流会：双线布局成果丰硕 海外业务占比超过60%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "业绩预告",
                        "海外业务",
                        "双线布局"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "新型防疫移动医院在沪投入使用",
                "features": {
                    "keywords": [
                        "防疫",
                        "移动医院",
                        "上海"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "公共卫生"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药行业重大事项点评：国务院发布药品带量采购意见 应采尽采 范围更广",
                "features": {
                    "keywords": [
                        "医药行业",
                        "国务院",
                        "带量采购",
                        "政策"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因本周市值蒸发156亿元 业绩预增难挽股价跌势 盈利能力下降",
                "features": {
                    "keywords": [
                        "华大基因",
                        "市值蒸发",
                        "盈利能力",
                        "股价下跌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "机构调研丨近期华大基因等接受调研 新冠检测需求有所增加",
                "features": {
                    "keywords": [
                        "华大基因",
                        "机构调研",
                        "新冠检测",
                        "需求增加"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：全球范围新冠检测需求比去年三季度有所增加",
                "features": {
                    "keywords": [
                        "华大基因",
                        "新冠检测",
                        "需求增加",
                        "全球范围"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "21股北向资金增持额超亿元，业绩预增股受青睐",
                "features": {
                    "keywords": [
                        "北向资金",
                        "增持",
                        "业绩预增"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物近七成公司年报预喜 机构看好行业长期投资价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "年报预喜",
                        "长期投资价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}